TriPath Imaging Announces Details of Conference Call to Discuss Agreement to be Acquired by Becton, Dickinson and Company
September 11 2006 - 12:28PM
PR Newswire (US)
BURLINGTON, N.C., Sept. 11 /PRNewswire-FirstCall/ -- TriPath
Imaging, Inc. (NASDAQ:TPTH) announced today that its conference
call with analysts and investors to discuss the Company's
announcement that it has signed a definitive merger agreement with
BD (Becton, Dickinson and Company) (NYSE:BDX) will be at 11 a.m. on
Wednesday, September 13, 2006. The call will be available by
dialing (888) 344-3716. International participants should call
(706) 634-4926. Individuals accessing the call may be required to
enter the conference call ID number 6385281. A live web cast of
TriPath Imaging's call will also be available online at
http://www.tripathimaging.com/. TriPath Imaging, Inc.,
headquartered in Burlington, North Carolina, develops,
manufactures, markets and sells innovative solutions to improve the
clinical management of cancer, including detection, diagnosis,
staging and treatment. TriPath Oncology, a wholly owned subsidiary
of TriPath Imaging, develops molecular diagnostic products for
malignant melanoma and cancers of the cervix, breast, ovary and
prostate. Additional company information is available at
http://www.tripathimaging.com/. IMPORTANT ADDITIONAL INFORMATION
WILL BE FILED WITH THE SEC TriPath Imaging plans to file with the
SEC and mail to its stockholders a Proxy Statement in connection
with the transaction. The Proxy Statement will contain important
information about BD, TriPath Imaging, the transaction and related
matters. Investors and security holders are urged to read the Proxy
Statement carefully when it is available. Investors and security
holders will be able to obtain free copies of the Proxy Statement
and other documents filed with the SEC by BD and TriPath Imaging
through the web site maintained by the SEC at http://www.sec.gov/.
In addition, investors and security holders will be able to obtain
free copies of the Proxy Statement from TriPath Imaging by
contacting TriPath Imaging, Inc., Investor Relations, 780
Plantation Drive, Burlington, NC 27215. TriPath Imaging and its
directors and executive officers may be deemed to be participants
in the solicitation of proxies in respect of the transactions
contemplated by the merger agreement. Information regarding TriPath
Imaging's directors and executive officers is contained in TriPath
Imaging's Form 10-K for the year ended December 31, 2005, its proxy
statement for the 2006 annual meeting of stockholders and its
Reports on Form 8-K filed with the SEC on June 30, 2006, July 25,
2006 and September 8, 2006. As of August 31, 2006, TriPath
Imaging's directors and executive officers beneficially owned
approximately 2,093,377 shares, or 5.4%, of TriPath Imaging's
common stock. A more complete description will be available in the
Proxy Statement. Contact Stephen P. Hall Chief Financial Officer
336-290-8721 DATASOURCE: TriPath Imaging, Inc. CONTACT: Stephen P.
Hall, Chief Financial Officer of TriPath Imaging, Inc.,
+1-336-290-8721 Web site: http://www.tripathimaging.com/
Copyright
Tripath Imaging (NASDAQ:TPTH)
Historical Stock Chart
From Jul 2024 to Aug 2024
Tripath Imaging (NASDAQ:TPTH)
Historical Stock Chart
From Aug 2023 to Aug 2024